• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    More On IMNP.ST

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Immune Pharmaceuticals, Inc. (IMNP.ST)

    -Stockholm
    17.90 Up 1.10(6.55%) 11:32AM EDT
    Add to Portfolio
    Prev Close:16.80
    Open:17.90
    Bid:16.80
    Ask:17.90
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:16.80 - 17.90
    52wk Range:14.15 - 29.90
    Volume:5,074
    Avg Vol (3m):3,294
    Market Cap:441.25M
    P/E (ttm):N/A
    EPS (ttm):-1.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in SEK.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes targeted therapeutics for the treatment of inflammatory diseases and cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback